Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001571049-14-001139
Filing Date
2014-04-10
Accepted
2014-04-10 21:24:24
Documents
2
Period of Report
2014-04-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1400626_daniel-welchf3.html 3  
1 OWNERSHIP DOCUMENT t1400626_daniel-welchf3.xml 3 5163
2 EXHIBIT 24 t1400626_ex24.htm EX-24 9966
  Complete submission text file 0001571049-14-001139.txt   16671
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2040 Grain Mill Products

Mailing Address 2 JOSHUA VALLEY ROAD EAST LYME CT 06333
Business Address
Welch Daniel A (Reporting) CIK: 0001603461 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36410 | Film No.: 14758521